Compass Therapeutics board member David Wurzer resigns for personal reasons

Compass Therapeutics, Inc.

David Wurzer resigned from the Board and all committees effective February 20, 2023.
Resignation was for personal family reasons, not due to any disagreement with the Company.
No replacement has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Wurzer

Director

CMPX · Compass Therapeutics, Inc.

Effective: 2023-02-20
Filed: February 24, 2023, 6:59 PM ET

On February 20, 2023, David Wurzer, a member of the Board of Directors (the “Board”) of Compass Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board, and all committees thereof, for personal family reasons effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Wurzer resigned as Director at Compass Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On February 20, 2023, David Wurzer, a member of the Board of Directors (the “Board”) of Compass Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board, and all committees thereof, for personal family reasons effective immediately.

View on SEC.gov

Compass Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001171843-23-001157

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.